Amexdrug

AXRX · OTC

$0.0002+$0.00 (+0.00%)TodayMarket closed · Jul 10, 9:30 AM ET

No price history for this range.

About AXRX

Amexdrug Corp. engages in the pharmaceutical, medical, and cosmeceutical industries. The company is headquartered in Beverly Hills, California and currently employs 9 full-time employees. The firm has eight business units, including Dermagen Inc., BioRx Pharma, BioRx Laboratories, Sponix Products, Royal Health Care, Amexhealth Plan and BioRx Labels. Dermagen Inc. manufactures pharmaceutical and skincare products, contract packaging and private labeling. BioRx Pharma unit is a manufacturer and distributor of pharmacy supplies, packaging and other health-care related products for pharmacy operations. BioRx Laboratories unit is a manufacturer and distributor of lab supplies and other related products for lab operations. BioRx Labels unit is a service provider of pharmacy labels. Sponix Products unit is health and wellness products for total health care. Royal Health Care develops and distributes nutraceuticals, nutritional supplements, vitamins and all-natural skincare products.

Employees: 11
Headquarters: Beverly Hills, California
Listed: Jul 21, 1972
Sector: Health Care
Industry: Health Care Providers & Services
Website: amexdrug.com

AXRX key statistics

Market cap: 30.00K
Price-earnings ratio: 0.07
Dividend yield: —
Average volume: 2.17K
Volume: 2.20K
Open price: $0.0002
High today: $0.0002
Low today: $0.0002
52 Week high: $0.0002
52 Week low: $0.0002

Amexdrug (AXRX) at a glance

Amexdrug (AXRX) last traded at $0.0002, with a market cap of 30.00K and a price-to-earnings ratio of 0.07.

Volume so far is 2.20K shares, in line with the average of 2.17K shares a day.

Similar companies

Companies in the same industry as Amexdrug

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.